Cargando…
The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy?
The mechanistic target of rapamycin (mTOR) is part of the phosphoinositide-3-kinase (PI3K)/protein kinase B (AkT)/mTOR pathway and owes its name to the inhibitory effect of rapamycin. The mTOR has a central converging role for many cell functions, serving as a sensor for extracellular signals from e...
Autores principales: | Lamberti, Giuseppe, Brighi, Nicole, Maggio, Ilaria, Manuzzi, Lisa, Peterle, Chiara, Ambrosini, Valentina, Ricci, Claudio, Casadei, Riccardo, Campana, Davide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877608/ https://www.ncbi.nlm.nih.gov/pubmed/29509701 http://dx.doi.org/10.3390/ijms19030747 |
Ejemplares similares
-
Prophylactic cholecystectomy is not mandatory in patients candidate to the resection for small intestine neuroendocrine neoplasms: a propensity score-matched and cost-minimization analysis
por: Ingaldi, Carlo, et al.
Publicado: (2021) -
Landscape and Future Perspectives of Immunotherapy in Neuroendocrine Neoplasia
por: Maggio, Ilaria, et al.
Publicado: (2020) -
Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors
por: Brighi, Nicole, et al.
Publicado: (2023) -
Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors
por: Lamberti, G., et al.
Publicado: (2017) -
A [68Ga]Ga-DOTANOC PET/CT Radiomic Model for Non-Invasive Prediction of Tumour Grade in Pancreatic Neuroendocrine Tumours
por: Bevilacqua, Alessandro, et al.
Publicado: (2021)